Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Morphic Holding Inc (NQ: MORF )

23.70 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 23.70
Bid (Size) 9.530 (1)
Ask (Size) 31.20 (2)
Prev. Close 23.70
Today's Range 23.70 - 23.70
52wk Range 19.34 - 63.08
Shares Outstanding 36,415,045
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Morphic Holding, Inc. Reminder: Robbins LLP is Investigating MORF on Behalf of Investors
From Robbins LLP
Via Business Wire
Morphic to Present at November Investor Conferences
From Morphic Therapeutic
Via GlobeNewswire

Performance

YTD
-9.44%
-9.44%
1 Month
+18.80%
+18.80%
3 Month
-56.97%
-56.97%
6 Month
-58.03%
-58.03%
1 Year
-13.88%
-13.88%

More News

Read More
Morphic Announces Corporate Highlights and Financial Results for the Third Quarter 2023
From Morphic Therapeutic
Via GlobeNewswire
Where Morphic Holding Stands With Analysts
Via Benzinga
NASDAQ: MORF Investor Notice: Investigation over Possible Securities Laws Violations by Morphic Holding, Inc.
Via SBWire
Morphic Holding Investigation: Johnson Fistel Encourages Shareholders with Losses to Contact the Firm Regarding Investigation
From Johnson Fistel, LLP
Via Business Wire
Morphic Holding SHAREHOLDER ALERT: Johnson Fistel Encourages Morphic Holding Shareholders with Losses to Contact the Firm Regarding Investigation
From Johnson Fistel, LLP
Via Business Wire
Morphic Therapeutic to Host Webcast to Present EMERALD-1 Full Data Set
From Morphic Therapeutic
Via GlobeNewswire
MORF INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Announces Investigation into Morphic Holding, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
Stock Market Rally Attempt Underway; Micron, Nike, Amazon, Meta In Focus: Weekly Review
Via Investor's Business Daily
Morphic Holdings Announces CEO Dr. Praveen Tipirneni to Take Temporary Medical Leave of Absence
From Morphic Therapeutic
Via GlobeNewswire
Gold Moves Lower; TransCode Therapeutics Shares Surge
Via Benzinga
Topics Stocks
Exposures US Equities
Morphic Therapeutic's Stock Plunges On Monday - Here's Why?
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Brainstorm Cell Therapeutics Shares Are Trading Lower By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
The Surprise That Prompted Morphic Therapeutic To Dump 52% Over Two Days
Via Investor's Business Daily
Nasdaq Turns Higher; SCYNEXIS Shares Plunge
Via Benzinga
Topics Stocks
Exposures US Equities
Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023
Via Benzinga
Morphic to Present Positive EMERALD-1 Phase 2a Data for MORF-057 in Patients with Moderate to Severe Ulcerative Colitis in Abstract for UEGW 2023
From Morphic Therapeutic
Via GlobeNewswire
Why Flux Power Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Morphic Announces Participation in 2023 Wells Fargo Healthcare Conference
From Morphic Therapeutic
Via GlobeNewswire
Morphic to Present at the Canaccord Genuity 43rd Annual Growth Conference
From Morphic Therapeutic
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2023
Via Benzinga
Morphic Announces Corporate Highlights and Financial Results for the Second Quarter 2023
From Morphic Therapeutic
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.